Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean W Felsher

Showing results (41-50 of 146) with videos related to

Pageof 15
Sort By:
Seminars in Cancer Biology|February 6, 2004
Conditional animal models: a strategy to define when oncogenes will be effective targets to treat cancerSylvie Giuriato, Karen Rabin, Alice C Fan, et al.
Frontiers in Oncology|August 18, 2022
Cyclic adenosine monophosphate/phosphodiesterase 4 pathway associated with immune infiltration and PD-L1 expression in lung adenocarcinoma cellsLing Tong, Minjie Shan, Wen Zou, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2003
Defective double-strand DNA break repair and chromosomal translocations by MYC overexpressionAsa Karlsson, Debabrita Deb-Basu, Athena Cherry, et al.
Blood|January 9, 2003
Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocationsAsa Karlsson, Sylvie Giuriato, Flora Tang, et al.
Cancer Biology & Therapy|November 5, 2008
(18)F and (18)FDG PET imaging of osteosarcoma to non-invasively monitor in situ changes in cellular proliferation and bone differentiation upon MYC inactivationConstadina Arvanitis, Pavan K Bendapudi, Jeffrey R Tseng, et al.
Scientific Reports|November 16, 2019
Mebendazole for Differentiation Therapy of Acute Myeloid Leukemia Identified by a Lineage Maturation IndexYulin Li, Daniel Thomas, Anja Deutzmann, et al.
Cancer Cell|August 14, 2014
MYC through miR-17-92 suppresses specific target genes to maintain survival, autonomous proliferation, and a neoplastic stateYulin Li, Peter S Choi, Stephanie C Casey, et al.
Plos One|June 19, 2008
Hepatotoxin-induced changes in the adult murine liver promote MYC-induced tumorigenesisShelly Beer, Kimberly Komatsubara, David I Bellovin, et al.
Journal for Immunotherapy of Cancer|November 22, 2018
Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinomaIan Lai, Srividya Swaminathan, Virginie Baylot, et al.
Plos Genetics|June 7, 2008
Combined analysis of murine and human microarrays and ChIP analysis reveals genes associated with the ability of MYC to maintain tumorigenesisChi-Hwa Wu, Debashis Sahoo, Constadina Arvanitis, et al.
Pageof 15

Showing results (41-50 of 146) with videos related to

Sort By:
Pageof 15
Seminars in Cancer Biology|February 6, 2004
Conditional animal models: a strategy to define when oncogenes will be effective targets to treat cancerSylvie Giuriato, Karen Rabin, Alice C Fan, et al.
Frontiers in Oncology|August 18, 2022
Cyclic adenosine monophosphate/phosphodiesterase 4 pathway associated with immune infiltration and PD-L1 expression in lung adenocarcinoma cellsLing Tong, Minjie Shan, Wen Zou, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2003
Defective double-strand DNA break repair and chromosomal translocations by MYC overexpressionAsa Karlsson, Debabrita Deb-Basu, Athena Cherry, et al.
Blood|January 9, 2003
Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocationsAsa Karlsson, Sylvie Giuriato, Flora Tang, et al.
Cancer Biology & Therapy|November 5, 2008
(18)F and (18)FDG PET imaging of osteosarcoma to non-invasively monitor in situ changes in cellular proliferation and bone differentiation upon MYC inactivationConstadina Arvanitis, Pavan K Bendapudi, Jeffrey R Tseng, et al.
Scientific Reports|November 16, 2019
Mebendazole for Differentiation Therapy of Acute Myeloid Leukemia Identified by a Lineage Maturation IndexYulin Li, Daniel Thomas, Anja Deutzmann, et al.
Cancer Cell|August 14, 2014
MYC through miR-17-92 suppresses specific target genes to maintain survival, autonomous proliferation, and a neoplastic stateYulin Li, Peter S Choi, Stephanie C Casey, et al.
Plos One|June 19, 2008
Hepatotoxin-induced changes in the adult murine liver promote MYC-induced tumorigenesisShelly Beer, Kimberly Komatsubara, David I Bellovin, et al.
Journal for Immunotherapy of Cancer|November 22, 2018
Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinomaIan Lai, Srividya Swaminathan, Virginie Baylot, et al.
Plos Genetics|June 7, 2008
Combined analysis of murine and human microarrays and ChIP analysis reveals genes associated with the ability of MYC to maintain tumorigenesisChi-Hwa Wu, Debashis Sahoo, Constadina Arvanitis, et al.
Pageof 15